Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Monte Rosa Therapeutics, Inc
Eastern Cooperative Oncology Group
University Health Network, Toronto
Wake Forest University Health Sciences
Essen Biotech
University of Oklahoma
Colorado State University
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
OncoNano Medicine, Inc.
Mayo Clinic
University of Salamanca
Wake Forest University Health Sciences
AC Camargo Cancer Center
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Colorado, Denver
Arab American University (Palestine)
Washington University School of Medicine
Washington University School of Medicine
Abramson Cancer Center at Penn Medicine
University of Alabama at Birmingham
Mayo Clinic
University Health Network, Toronto
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
RAPT Therapeutics, Inc.
Cyteir Therapeutics, Inc.
University of Toronto
Actuate Therapeutics Inc.
Zhejiang Provincial People's Hospital
Washington University School of Medicine
Cedars-Sinai Medical Center
Rigshospitalet, Denmark
Celldex Therapeutics
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Eisai Inc.
Association Francaise pour la Recherche Thermale
OHSU Knight Cancer Institute
Haukeland University Hospital
South Tees Hospitals NHS Foundation Trust
Icahn School of Medicine at Mount Sinai
Cellestia Biotech AG
Corvus Pharmaceuticals, Inc.